Patho-physiology of urease: urease inhibiters as a significant therapeutic goal.
The experimental findings suggested that infections produced by bacteria such as Helicobacter pylori and Proteus mirabilis usually have a high urease activity. Urease is central toH. pylorimetabolism and virulence, necessary for its colonization in gastric mucosa [5,6]. It is a potent immunogen that elicits a strong immune response. Urease represents an interesting model for metalloenzyme studies. Before the discovery ofH pylori, urease production was limited to human physiology. But now the contribution of this bacterium in urease production is well established. It contributes in urinary tract and gastrointestinal infections, probably augmenting the severity of several pathological conditions like peptic ulcers and stomach cancer etc. Ureases are also involved in the development of different human and animal pathogenicity such as urolithiasis, pyelonephritis, hepatic encephalopathy, hepatic coma and urinary catheter encrustation [7-9]. Over urease production is also contributing in environmental hazards.
The enzyme has been recognized that it is one of the key agents in the pathophysiology of multiple human and animal disorders, targeting urease for treating pathogenic disorders caused by urease-producing- bacteria has already open a new line of treatment for infections caused by such bacteria. In reality more effective and potent compounds are mandatory with a complete new level of safety and specificity. Urease inhibitors for this purpose have gained incredible attention in recent times and therefore resulted into the discovery of numerous inhibitors [8,10-13].
To summarize, urease inhibitors are highly potential target for different pathological conditions induced urease hyperactivity.
[1.] Khan AW (2012) Phytochemical analysis and enzyme inhibition assay of Aervajavanica for ulcer. Chem Central J 6:76
[2.] Khan H, Saeed M, Muhammad N, Gaffar R, Gul F, et al. (2013) Lipoxygenase and urease inhibition of the aerial parts of the Polygonatumverticillatum. ToxicolInd Health: Epub ahead of print.
[3.] Khan H, Ali Khan M, Hussain I (2007) Enzyme inhibition activities of the extracts from rhizomes of Gloriosa superba Linn (Colchicaceae). J Enzyme Inhib Med Chem 22: 722-725.
[4.] Lateef M (2012) Evaluation of antioxidant and urease inhibition activities of roots of Glycyrrhiza glabra. Pak J Pharm Sci 25: 99-102.
[5.] Khan MA, Khan H, Tariq SA, Pervez S (2014) Urease inhibitory activity of aerial parts of Artemisia scoparia: Explorationinan in vitro study. Ulcers 5:1-5.
[6.] Khan H, Khan MA (2014) Antiulcer Effect of Extract/Fractions of Eruca sativa Attenuation of Urease Activity. J Evid Based Complementary Altern Med 19: 176-180.
[7.] Kuwahara H, Miyamoto Y, Akaike T, Kubota T, Sawa T (2000) Helicobacter pylori Urease Suppresses Bactericidal Activity of Peroxynitrite via Carbon Dioxide Production. Infect Immun 68: 4378-4383.
[8.] Zhu-Ping X, Da-Hua S, Huan-Qiu L, Li-Na Z, Chen X, et al. (2007) Polyphenols based on isofavones as inhibitors of Helicobacter pylori urease. Bioorg Med Chem 15: 3703-3710.
[9.] Uddin N, Siddiqui BS, Begum S, Ali MI, Marasini BP, et al. (2013) Bioassay-guided isolation of urease and a-chymotrypsin inhibitory constituents from the stems of Lawsonia alba Lam.(Henna). Fitoterapia 84: 202-207.
[10.] Hanif M, Shoaib K, Saleem M, Rama NH, Zaib S, et al. (2012) Synthesis, urease Inhibition, antioxidant, antibacterial, and molecular docking studies of 1,3,4-oxadiazole derivatives. ISRN Pharmacol 2012: 1-9.
[11.] Uesato S, Hashimoto Y, Nishino M, Nagaoka Y, Kuwajima H (2002) N- substituted hydroxyureas as urease inhibitors,". Chem Pharm Bull 50: 1280-1282.
[12.] Tariq SA (2011) Urease inhibitors from Indigoferagerardiana Wall. J Enz Inhibition Med Chem 26: 480-484.
[13.] Khan H, Saeed M, Khan MA, Muhammad N, Khan A, et al. (2014) Lipoxygenase and Urease Inhibition of Extracts of Polygonatum verticillatum Rhizome: Augmented by its Isolated Compound, Santonin. J ChemSoc Pak 36: 865-869.
Haroon Khan *
Department of Pharmacy, Abdul Wali Khan University Mardan 23200, Pakistan
* Corresponding author: Khan H, Department of Pharmacy, Abdul Wali Khan University Mardan 23200, Pakistan, Tel: +92- 3329123171; E-mail: email@example.com
Received date: January 26 2015, Accepted date: January 27 2015, Published date: February 4 2015
|Printer friendly Cite/link Email Feedback|
|Publication:||Biology and Medicine|
|Date:||Jul 1, 2015|
|Previous Article:||Traditional role of morels (morchella spp.) as food, medicine and income in Palas valley, Pakistan.|
|Next Article:||Advocating for reduced sugar consumption to reduce the prevalence of non-communicable diseases.|